Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2011

01-10-2011 | American Society of Breast Surgeons

Perceptions of Contralateral Breast Cancer: An Overestimation of Risk

Authors: Andrea Abbott, MD, Natasha Rueth, MD, MS, Susan Pappas-Varco, RN, Karen Kuntz, ScD, Elizabeth Kerr, RN, Todd Tuttle, MD, MS

Published in: Annals of Surgical Oncology | Issue 11/2011

Login to get access

Abstract

Introduction

The rate of contralateral prophylactic mastectomy (CPM) has recently increased. The aim of this study is to assess perceptions of contralateral breast cancer (CBC) risk among breast cancer patients and to evaluate tumor and patient factors associated with risk perception.

Methods

We conducted a prospective survey study to evaluate perceptions of CBC risk in women newly diagnosed with ductal carcinoma in situ (DCIS) or stage I/II invasive breast cancer. Surveys were distributed in clinic prior to surgical consultation. Exclusion criteria included history of breast cancer, bilateral breast cancer, neoadjuvant chemotherapy or radiation for the current breast cancer, or BRCA mutation. Survey questions used open-ended responses or five-point Likert scale scoring (5 = very likely, 1 = not at all likely).

Results

Seventy-four women (mean age 54.5 years) completed the survey. Diagnoses included invasive ductal cancer (66.2%), invasive lobular cancer (9.5%), and DCIS (20.3%). Most women (54.1%) underwent breast-conserving surgery; the remaining had bilateral mastectomy including CPM (17.6%) or unilateral mastectomy (10.8%). Overall, women substantially overestimated their risk of developing CBC. The mean estimated 10-year risk of CBC was 31.4% [95% confidence interval (CI) 24.7–37.9%] and 2.6 ± 0.15 on the rank scale. The perceived risk of CBC was not significantly associated with cancer stage, family history, age, or CPM.

Conclusions

At time of surgical evaluation, women with unilateral breast cancer substantially overestimated their risk of CBC; however, this elevated risk perception was not associated with choosing CPM. Early physician counseling is needed to provide women with accurate information regarding their true CBC risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985;68:99–112.PubMed Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985;68:99–112.PubMed
2.
go back to reference Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–45.PubMedCrossRef Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–45.PubMedCrossRef
3.
go back to reference Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. doi:10.1200/JCO.2010.32.7395 (online March 14 2011). Nichols HB, Berrington de Gonzalez A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. doi:10.​1200/​JCO.​2010.​32.​7395 (online March 14 2011).
4.
go back to reference Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC Trial. Lancet. 2010;11:1135–41.CrossRef Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC Trial. Lancet. 2010;11:1135–41.CrossRef
5.
go back to reference Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–9.PubMedCrossRef Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203–9.PubMedCrossRef
6.
go back to reference Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.PubMedCrossRef Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27:1362–7.PubMedCrossRef
7.
go back to reference Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77:285–93.PubMedCrossRef Rakovitch E, Franssen E, Kim J, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2003;77:285–93.PubMedCrossRef
8.
go back to reference Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328–35.PubMedCrossRef Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2004;22:2328–35.PubMedCrossRef
9.
go back to reference McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy. Trends in use from 1995 through 2005. Cancer. 2009;115:5404–12.PubMedCrossRef McLaughlin CC, Lillquist PP, Edge SB. Surveillance of prophylactic mastectomy. Trends in use from 1995 through 2005. Cancer. 2009;115:5404–12.PubMedCrossRef
10.
go back to reference Sobrero ME, Dick AW, Beckjord EB, et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597–605.CrossRef Sobrero ME, Dick AW, Beckjord EB, et al. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16:1597–605.CrossRef
11.
go back to reference Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–96.PubMedCrossRef Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–96.PubMedCrossRef
12.
go back to reference Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. JNCI. 2008;100:243–51.PubMed Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. JNCI. 2008;100:243–51.PubMed
13.
go back to reference Black WC, Nease RF, Tosteson ANA. Perception of breast cancer risk and screening effectiveness in women younger than 50 years of age. JNCI. 1995;87:720–31.PubMed Black WC, Nease RF, Tosteson ANA. Perception of breast cancer risk and screening effectiveness in women younger than 50 years of age. JNCI. 1995;87:720–31.PubMed
14.
go back to reference Alexander NE, Ross J, Sumner W, Nease RF, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med. 1996;11:92–7.PubMedCrossRef Alexander NE, Ross J, Sumner W, Nease RF, Littenberg B. The effect of an educational intervention on the perceived risk of breast cancer. J Gen Intern Med. 1996;11:92–7.PubMedCrossRef
15.
go back to reference Quillin JM, McClish DK, Jones RM, et al. Duration of an intervention’s impact on perceived breast cancer risk. Health Educ Behav. 2008;35:855–65.PubMedCrossRef Quillin JM, McClish DK, Jones RM, et al. Duration of an intervention’s impact on perceived breast cancer risk. Health Educ Behav. 2008;35:855–65.PubMedCrossRef
16.
go back to reference Altschuler A, Nekhlyudov L, Rolnick SJ, et al. Positive, negative, and disparate-women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14:25–32.PubMedCrossRef Altschuler A, Nekhlyudov L, Rolnick SJ, et al. Positive, negative, and disparate-women’s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008;14:25–32.PubMedCrossRef
Metadata
Title
Perceptions of Contralateral Breast Cancer: An Overestimation of Risk
Authors
Andrea Abbott, MD
Natasha Rueth, MD, MS
Susan Pappas-Varco, RN
Karen Kuntz, ScD
Elizabeth Kerr, RN
Todd Tuttle, MD, MS
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 11/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1914-x

Other articles of this Issue 11/2011

Annals of Surgical Oncology 11/2011 Go to the issue

American Society of Breast Surgeons

Can We Measure the Quality of Breast Surgical Care?